BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20116742)

  • 1. [Prognostic markers of COPD. Role of comorbidity].
    Alvarez FV; Romero GP
    Arch Bronconeumol; 2009; 45 Suppl 4():2-7. PubMed ID: 20116742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidities as an element of multidimensional prognostic assessment of patients with chronic obstructive pulmonary disease.
    Grabicki M; Parysek H; Batura-Gabryel H; Brodnicka I
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():297-301. PubMed ID: 19218653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary care of the patient with chronic obstructive pulmonary disease-part 4: understanding the clinical manifestations of a progressive disease.
    Cooper CB; Dransfield M
    Am J Med; 2008 Jul; 121(7 Suppl):S33-45. PubMed ID: 18558106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of mortality in COPD.
    Celli BR
    Respir Med; 2010 Jun; 104(6):773-9. PubMed ID: 20417082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients.
    Soler-Cataluña JJ; Martínez-García MA; Sánchez LS; Tordera MP; Sánchez PR
    Respir Med; 2009 May; 103(5):692-9. PubMed ID: 19131231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?
    Soler-Cataluña JJ; Rodriguez-Roisin R
    COPD; 2010 Aug; 7(4):276-84. PubMed ID: 20673037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality in COPD: Role of comorbidities.
    Sin DD; Anthonisen NR; Soriano JB; Agusti AG
    Eur Respir J; 2006 Dec; 28(6):1245-57. PubMed ID: 17138679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposal for a multidimensional staging system for chronic obstructive pulmonary disease.
    Celli BR; Calverley PM; Rennard SI; Wouters EF; Agusti A; Anthonisen N; Macnee W; Jones P; Pride N; Rodriguez-Roisin R; Rossi A; Wanner A
    Respir Med; 2005 Dec; 99(12):1546-54. PubMed ID: 16291077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
    Celli BR; Cote CG; Marin JM; Casanova C; Montes de Oca M; Mendez RA; Pinto Plata V; Cabral HJ
    N Engl J Med; 2004 Mar; 350(10):1005-12. PubMed ID: 14999112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
    Soler-Cataluña JJ; Martínez-García MA; Román Sánchez P; Salcedo E; Navarro M; Ochando R
    Thorax; 2005 Nov; 60(11):925-31. PubMed ID: 16055622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease: linking outcomes and pathobiology of disease modification.
    Rennard SI
    Proc Am Thorac Soc; 2006 May; 3(3):276-80. PubMed ID: 16636098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of risk of COPD exacerbations by the BODE index.
    Marin JM; Carrizo SJ; Casanova C; Martinez-Camblor P; Soriano JB; Agusti AG; Celli BR
    Respir Med; 2009 Mar; 103(3):373-8. PubMed ID: 19013781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease.
    Yetkin O; Gunen H
    Clin Respir J; 2008 Jan; 2(1):36-40. PubMed ID: 20298302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.
    Antonescu-Turcu AL; Tomic R
    Curr Opin Pulm Med; 2009 Mar; 15(2):120-5. PubMed ID: 19532026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [COPD and systemic inflammation. A link for comorbidity].
    Agustí A
    Arch Bronconeumol; 2009; 45 Suppl 4():14-7. PubMed ID: 20116744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic goals and outcome measurements in COPD patients].
    Morr H
    Med Klin (Munich); 2006 Apr; 101(4):279-82. PubMed ID: 16607483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic obstructive pulmonary disease and cardiovascular system].
    Gürgün A; Gürgün C
    Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of exacerbations on the clinical course of chronic obstructive pulmonary disease].
    Soler-Cataluña JJ; Martínez-García MA; Catalán Serra P; Román Sánchez P
    Rev Clin Esp; 2011 Mar; 211 Suppl 2():3-12. PubMed ID: 21596168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.